drugset / Trial / NCT00170963

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

NCT00170963

Phase 3 Completed 1018 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication

Timeline

Start
2004-10
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Subject Valsartan Small molecule 160 mg

Indications